RE:RE:Cash on handCogt: agree that a take out is near. Not now though as their share price is too low. I stated last week that once it's trading in the 50 Canadian range then a forty percent premium is justified by the buyer and takes it to 70-75 CAN. Cxr is fighting an uphill losing battle in the present environment as their growth by acquisition model is no longer applauded nor rewarded by the markets. Selling the company makes sense especially since they do have a nice profitable profile of drugs. Take the money and run I believe is their best bet. In my opinion it's just a matter of time.